FindTrial
Sign In

Prospective intrapatient Comparison of MRI-based risk models, intraoperative Cerenkov luminescence imaging and printed 3D-models to detect extracapsular extension in intermediate- and high-risk prostate cancer

Prospective intrapatient Comparison of MRI-based risk models, intraoperative Cerenkov luminescence imaging and printed 3D-models to detect extracapsular extension in intermediate- and high-risk prostate cancer - PRIMER

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00025059
Enrollment
15
Registered
2021-05-03
Start date
2021-05-20
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C61

Interventions

Group 1: Radical prostatectomy, comparison of preoperative MR-based risk models, 3D printed models and Cherenkov luminescence

Sponsors

Universitätsklinikum Essen
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
45 Years to 80 Years

Inclusion criteria

Inclusion criteria: Indication for radical prostatectomy, intermediate- and high-risk prostate cancer

Exclusion criteria

Exclusion criteria: low-risk prostate cancer

Design outcomes

Primary

MeasureTime frame
Rate of correct predicted extracapsular tumor extension in percent—

Secondary

MeasureTime frame
Reduction of positive surgical margins—

Countries

Germany

Contacts

Public ContactJan Philipp Radtke

Urologische Klinik Universitätsklinikum Essen

janphilipp.radtke@uk-essen.de020172383069

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026